Deletion of the Npr3 gene increases severity of acute lung injury in obese mice

Abstract Previous studies have shown that atrial natriuretic peptide (ANP) attenuates agonist‐induced pulmonary edema and that this effect may be mediated in part by the ANP clearance receptor, natriuretic peptide receptor‐C (NPR‐C). Obesity has been associated with lower plasma ANP levels due to increased expression of NPR‐C, and with decreased severity of acute lung injury (ALI). Therefore, we hypothesized that increased expression of NPR‐C may attenuate ALI severity in obese populations. To test this, we examined ALI in Npr3 wild‐type (WT) and knockout (KO) mice fed normal chow (NC) or high‐fat diets (HFD). After 12 weeks, ALI was induced with intra‐tracheal administration of Pseudomonas aeruginosa strain 103 (PA103) or saline. ALI severity was determined by lung wet‐to‐dry ratio (W/D) along with measurement of cell count, protein levels from bronchoalveolar lavage fluid (BALF), and quantitative polymerase chain reaction was performed on whole lung to measure cytokine/chemokine and Npr3 mRNA expression. ANP levels were measured from plasma. PA103 caused ALI as determined by significant increases in W/D, BALF protein concentration, and whole lung cytokine/chemokine expression. PA103 increased Npr3 expression in the lungs of wild‐type (WT) mice regardless of diet. There was a nonsignificant trend toward increased Npr3 expression in the lungs of WT mice fed HFD versus NC. No differences in ALI were seen between Npr3 knockout (KO) mice and WT‐fed NC, but Npr3 KO mice fed HFD had a significantly greater W/D and BALF protein concentration than WT mice fed HFD. These findings support the hypothesis that Npr3 may help protect against ALI in obesity.

[1]  A. Alli,et al.  C Type Natriuretic Peptide Receptor Activation Inhibits Sodium Channel Activity in Human Aortic Endothelial Cells by Activating the Diacylglycerol-Protein Kinase C Pathway , 2022, International journal of molecular sciences.

[2]  Zachary S. Wilson,et al.  Natriuretic Peptide Receptor-C mediates the inhibitory Effect of Atrial Natriuretic Peptide on Neutrophil Recruitment to the Lung during Acute Lung Injury. , 2022, American journal of physiology. Lung cellular and molecular physiology.

[3]  Dao-xin Wang,et al.  Adipose-Derived Circulating Exosomes Promote Protection of the Pulmonary Endothelial Barrier by Inhibiting EndMT and Oxidative Stress through Down-Regulation of the TGF-β Pathway: A Potential Explanation for the Obesity Paradox in ARDS , 2022, Oxidative medicine and cellular longevity.

[4]  M. Beudel,et al.  Overweight and Obesity Are Associated With Acute Kidney Injury and Acute Respiratory Distress Syndrome, but Not With Increased Mortality in Hospitalized COVID-19 Patients: A Retrospective Cohort Study , 2021, Frontiers in Endocrinology.

[5]  O. Ziegler,et al.  Obesity and mortality in critically ill COVID-19 patients with respiratory failure , 2021, International Journal of Obesity.

[6]  E. Egom Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF) , 2021, Frontiers in Physiology.

[7]  Karin de Punder,et al.  Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review , 2021, Cells.

[8]  L. Nagy,et al.  Diet-dependent natriuretic peptide receptor C expression in adipose tissue is mediated by PPARγ via long-range distal enhancers , 2021, bioRxiv.

[9]  M. Zeitlinger,et al.  Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey , 2020, Critical Care.

[10]  A. Hobbs,et al.  C-Type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature , 2019, International journal of molecular sciences.

[11]  He Yu,et al.  Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis , 2017, Critical Care.

[12]  Liu Shuying,et al.  “Obesity Paradox” in Acute Respiratory Distress Syndrome: Asystematic Review and Meta-Analysis , 2016, PloS one.

[13]  Anders Larsson,et al.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.

[14]  Hao Wang,et al.  Atrial natriuretic peptide in cardiovascular biology and disease (NPPA). , 2015, Gene.

[15]  D. Joanisse,et al.  Defective Natriuretic Peptide Receptor Signaling in Skeletal Muscle Links Obesity to Type 2 Diabetes , 2015, Diabetes.

[16]  R. Lucas,et al.  The Acute Respiratory Distress Syndrome: Mechanisms and Perspective Therapeutic Approaches. , 2015, Austin journal of vascular medicine.

[17]  M. Okumura,et al.  Atrial natriuretic peptide inhibits lipopolysaccharide-induced acute lung injury. , 2014, Pulmonary pharmacology & therapeutics.

[18]  K. Skaltsa,et al.  Evaluation of the PaO2/FiO2 ratio after cardiac surgery as a predictor of outcome during hospital stay , 2014, BMC Anesthesiology.

[19]  J. Machan,et al.  Atrial natriuretic peptide attenuates agonist-induced pulmonary edema in mice with targeted disruption of the gene for natriuretic peptide receptor-A. , 2013, Journal of applied physiology.

[20]  A. Malhotra,et al.  Obesity and ARDS. , 2012, Chest.

[21]  D. Mohapatra,et al.  The C-Type Natriuretic Peptide Induces Thermal Hyperalgesia through a Noncanonical Gβγ-dependent Modulation of TRPV1 Channel , 2012, The Journal of Neuroscience.

[22]  L. Potter Natriuretic peptide metabolism, clearance and degradation , 2011, The FEBS journal.

[23]  D. Christiani,et al.  Body mass index and acute kidney injury in the acute respiratory distress syndrome , 2011, Critical care medicine.

[24]  K. Nakao,et al.  Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. , 2011, Journal of cardiology.

[25]  N. O. Belo,et al.  Natriuretic peptide system: A link between fat mass and cardiac hypertrophy and hypertension in fat-fed female rats , 2011, Regulatory Peptides.

[26]  A. Klibanov,et al.  Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[27]  L. Nielsen,et al.  Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice. , 2010, Endocrinology.

[28]  P. Parsons,et al.  The association between BMI and plasma cytokine levels in patients with acute lung injury. , 2010, Chest.

[29]  E. Bajwa,et al.  Body mass index is associated with the development of acute respiratory distress syndrome , 2009, Thorax.

[30]  Elena Alekseeva,et al.  Epac/Rap and PKA are novel mechanisms of ANP‐induced Rac‐mediated pulmonary endothelial barrier protection , 2008, Journal of cellular physiology.

[31]  J. Sznajder,et al.  Alveolar epithelium and Na,K-ATPase in acute lung injury , 2007, Intensive Care Medicine.

[32]  G. Marcus,et al.  Obese patients have lower B-type and atrial natriuretic peptide levels compared with nonobese. , 2006, Congestive heart failure.

[33]  S. Lemeshow,et al.  Body mass index is independently associated with hospital mortality in mechanically ventilated adults with acute lung injury* , 2006, Critical Care Medicine.

[34]  N. Maeda,et al.  The role of natriuretic peptides in cardioprotection. , 2006, Cardiovascular research.

[35]  D. Irwin,et al.  Direct ANP inhibition of hypoxia-induced inflammatory pathways in pulmonary microvascular and macrovascular endothelial monolayers. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[36]  D. Levy,et al.  Impact of Obesity on Plasma Natriuretic Peptide Levels , 2004, Circulation.

[37]  R. Macallister,et al.  Vascular natriuretic peptide receptor‐linked particulate guanylate cyclases are modulated by nitric oxide–cyclic GMP signalling , 2003, British journal of pharmacology.

[38]  T. Hunter,et al.  Guanylyl Cyclase-linked Natriuretic Peptide Receptors: Structure and Regulation* , 2001, The Journal of Biological Chemistry.

[39]  H. Zhou,et al.  G(i-1)/G(i-2)-dependent signaling by single-transmembrane natriuretic peptide clearance receptor. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[40]  M. Yamauchi,et al.  The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Y. Hirata,et al.  Beneficial effect of atrial natriuretic peptide on pulmonary gas exchange in patients with acute lung injury. , 1998, Chest.

[42]  M. Kitajima,et al.  Effect of acute lung injury and coexisting disorders on plasma concentrations of atrial natriuretic peptide , 1994, Critical care medicine.

[43]  R. A. Rutherford,et al.  Identification of renal natriuretic peptide receptor subpopulations by use of the non‐peptide antagonist, HS‐142‐1 , 1994, British journal of pharmacology.

[44]  M. Volpe,et al.  Salt‐Regulating Hormones in Young Normotensive Obese Subjects: Effects of Saline Load , 1994, Hypertension.

[45]  N. Minamino,et al.  C-type natriuretic peptide inhibits intimal thickening after vascular injury. , 1993, Biochemical and biophysical research communications.

[46]  D. Goeddel,et al.  Molecular Biology of the Natriuretic Peptides and Their Receptors , 1992, Circulation.

[47]  A. Birukova,et al.  Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction. , 2011, Journal of applied physiology.

[48]  M. Emdin,et al.  The paradox of low BNP levels in obesity , 2011, Heart Failure Reviews.

[49]  L. R. Potter,et al.  Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. , 2009, Handbook of experimental pharmacology.